Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1537
| Despition | YY1 Human Recombinant |
| SIZE | 5 µg |
| Purity | > 80.0% (SDS-PAGE) |
| Form | Sterile Filtered clear solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1660 | Mouse GDF7 Protein (AC1660) | 2 µg | inquiry |
| ACPP-1353 | PDE7B Blocking Peptide (AC1353) | 250 µg | inquiry |
| ACPP-1512 | Human UBE2K Protein (AC1512) | 2 µg | inquiry |
| ACPP-1013 | Recombinant Human GPCR GPRC5B Protein (Fc Tag) (AC1013) | 50 µg | inquiry |
| ACPP-1101 | Recombinant Human SIRP alpha Protein (Fc Tag) (AC1101) | 50 µg | inquiry |
| ACPP-1283 | Human LGALS7 Protein, His (AC1283) | 5 µg | inquiry |
| ACPP-1195 | CaMKII gamma Blocking Peptide (AC1195) | 250 µg | inquiry |
| ACPP-1673 | Human TIMM8A Protein (AC1673) | 5 µg | inquiry |
| ACPP-1298 | Syndecan-1 Blocking Peptide (AC1298) | 250 µg | inquiry |
| ACPP-1823 | Human SOX2 Protein, TAT (AC1823) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.